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ABSTRACT 
The l i m i t e d  l e g a l i z a t i o n  of d iace ty lmorphine  ( h e r o i n )  f o r  use i n  t h e  medical  
t r ea tmen t  of i n t r a c t a b l e  pain i s  d i scussed  i n  a whi te  paper which a t t empt s  t o  
p re sen t  pros  and cons on the  i s s u e  a s  wel l  a s  in format ion  on pending l e g i s l a t i o n .  
The paper a l s o  provides  a  canpar i son  of h e r o i n ' s  a n a l g e s i c  q u a l i t i e s  t o  t hose  of 
c u r r e n t l y  a v a i l a b l e  and equ iva l en t  pharmaceut ical  a l t e r n a t i v e s .  
HEROIN: LEGALIZATION FOR MEDICAL USE 
Over t h e  p a s t  few years  a  g r e a t  d e a l  of a t t e n t i o n  has  focused on t h e  emo- 
t i o n a l l y  charged i s s u e  involving the  l e g a l i z a t i o n  of he ro in  f o r  medical purposes ,  
e s p e c i a l l y  f o r  t h e  t e r m i n a l l y  ill s u f f e r i n g  from i n t r a c t a b l e  pa in .  Heroin,  a n  
o p i a t e  d e r i v a t i v e ,  i s  sub jec t  t o  c o n t r o l  under Schedule I of t h e  Con t ro l l ed  Sub- 
s t a n c e s  Act ( T i t l e  I1 of t h e  Comprehensive Drug Abuse Prevent ion  and Con t ro l  Act 
of 1970).  Drugs placed i n  t h i s  schedule  meet t h e  fo l lowing  c r i t e r i a :  (1) t h e  
drug' o r  o t h e r  subs tance  has a  high p o t e n t i a l  f o r  abuse;  ( 2 )  t h e  drug  o r  o t h e r  
subs t ance  has  no c u r r e n t l y  accepted medical u s e  i n  t rea tment  i n  the  United 
S t a t e s ;  and (3) t h e r e  i s  a  l a c k  of accepted s a f e t y  f o r  use of t h e  drug o r  sub- 
s t a n c e  under medical superv is ion .  Proponents  of t he  l e g a l i z a t i o n  of he ro in  
( i . e . ,  having h e r o i n  rescheduled,  probably down t o  Schedule 11)  most o f t e n  a rgue  
t h a t ,  c o n t r a r y  t o  t h e  second schedul ing requirement  of Schedule I (no  c u r r e n t l y  
accepted medical  u s e ) ,  t h e  substance does have a  p l ace  of b e n e f i t  i n  our arma- 
mentarium of drugs t o  r e l i e v e  pain. 
The p r i n c i p a l  argument i n  favor  of t he  use of he ro in  a s  an ana1gesi.c i s  
t h a t  i t  i s  more po ten t  and t h e r e f o r e  can be adminis te red  i n  sma l l e r  doses  t h a n  
most o t h e r  n a r c o t i c  a n a l g e s i c s ,  inc lud ing  morphine. Th i s  may be t r u e  f o r  e a r l y  
e f f e c t s  i n  t h a t  he ro in  passes  t he  blood-brain b a r r i e r  more r a p i d l y  than  does  
morphine. However, h e r o i n  is  then r a p i d l y  hydrolyzed to  rmrphine i n  the  body 
and a c t s  t h e r e a f t e r  a s  morphine does i n  pa in  c o n t r o l .  - 1/ Fur the r  r e s e a r c h  may 
1/ J a f f e ,  J e r a n e  H . ,  and William R. Martin.  I n  Goodman and Gilman, The 
~ h a r 6 c b l o ~ i c a l  Basis  of  Therapeut ics  [6 th  e d .  1. New York, MacMillian, 1980. 
p., 506-507. 
uncover s u b j e c t i v e  o r  he re to fo re  unknown b e n e f i t s  t h a t  may a l t e r  t h i s  explana-  
t i o n  of h e r o i n ' s  mechanism of a c t i o n .  
The fo l l owing  arguments have been made a g a i n s t  a  change i n  F e d e r a l  l a w  t o  
permi t  t h e  use  of h e r o i n  t o  c o n t r o l  pa in :  
1. On an i n t e r n a t i o n a l  l e v e l ,  t h e  United S t a t e s  i s  pa r ty  t o  t he  
1961 S i n g l e  Convention on Narco t i c  Drugs,  which r e s t r i c t s  t h e  u se  
of opium and i t s  d e r i v a t i v e s .  
2 .  The United S t a t e s  i s  a l s o  p a r t y  t o  a World Heal th  Organ iza t ion  
agreement  (WHO Assembly Resolu t ion  No. 1 4 )  t o  d i s con t inue  t h e  
medica l  use  of hero in  because of i t s  a d d i c t i o n  producing q u a l i -  
t i e s ,  and because o t h e r ,  l e s s  harmful drugs a r e  a v a i l a b l e  f o r  
such medical  purposes. 
3. The a c t i o n  of morphine i n  l a r g e r  doses  i s  g e n e r a l l y  e q u i v a l e n t  
t o  t h a t  of h e r o i n  and i n  e i t h e r  c a s e  dosage must be below t h a t  
which would produce r e s p i r a t o r y  a r r e s t .  
4. N a r c o t i c s  c o n t r o l  a u t h o r i t i e s  do no t  want a d d i c t i v e  h e r o i n  i n  
l e g a l  use  i n  t he  United S t a t e s  a s  t h i s  would r e q u i r e  c a r e f u l  
s u r v e i l l a n c e  i n  lockup c a b i n e t s  i n  American h o s p i t a l s .  
5. Drugs many t imes more po ten t  than he ro in  o r  morphine a r e  being 
developed f o r  pain c o n t r o l ,  t h e  a t t e n t i o n  being focused on de- 
c r ea sed  t o l e r a n c e  and on an accep tab l e  l e v e l  of s a f e t y  and 
e f f e c t i v e n e s s .  I n  1980, t h e  N a t i o n a l  Cancer I n s t i t u t e  developed 
a form of f reeze-dr ied m r p h i n e  t h a t  i s  very  so lub le  and a s  a  
r e s u l t  a l l ows  high doses  t o  be adminis te red  i n  l e s s  than one 
m i l l i l i t e r  (one mill i l i ter  equa ls  approximately one-quarter  
t easpoon) .  
6. Unlike morphine, hero in  is  u n s t a b l e  i n  s o l u t i o n  and may have 
t o  be mixed da i ly .  
7. I n  some cases ,  t h e  b e t t e r  s o l u t i o n  t o  te rmina l  i n t r a c t a b l e  pa in  
i s  a  cordotomy, a  procedure performed by a  neurosurgeon i n  which 
t h e  a p p r o p r i a t e  pain nerve i s  severed .  
I n  o r d e r  t o  determine the  p o s s i b l e  va lue  of he ro in  compared t o  o t h e r  power- 
f u l  a n a l g e s i c s ,  t h e  U.S.  Government has  supported c o n t r o l l e d  s t u d i e s  conducted 
by t h e  Vincent  T. Lombardi Cancer Research Center a t  Georgetown U n i v e r s i t y  i n  
Washington, D . C . ,  and by the  Memorial Sloan-Ketter ing Cancer Cen te r  i n  New York. 
The Sloan-Ketter ing s tudy was designed t o  determine t h e  r e l a t i v e  potency of 
i n t r a m u s c u l a r  he ro in  and morphine i n  cancer  p a t i e n t s  wi th  p o s t o p e r a t i v e  pa in .  21  - 
The i n v e s t i g a t o r s  repor ted  t he  fo l lowing  conc lus ions :  
( a )  h e r o i n  was about twice a s  po t en t  a s  morphine; 
( b )  he ro in  provided an ana lges i c  peak e f f e c t  e a r l i e r  t han  morphine; 
( c )  doses  wi th  equal ana lges i c  e f f e c t s  provided comparable improve- 
ments i n  var ious  elements of mood; 
( d )  peak mood improvement occurred e a r l i e r  a f t e r  hero in ;  
( e )  both a n a l g e s i c  and mood improvement were l e s s  s u s t a i n e d  a f t e r  
h e r o i n  a t  doses providing equa l  peak a n a l g e s i c  e f f e c t s ;  
( f )  s l e e p i n e s s  was t h e  most f r equen t  s i d e  e f f e c t  a f t e r  both d rugs ;  and 
( g )  h e r o i n  has no unique advantages o r  disadvantages f o r  t he  r e l i e f  of 
pa in  i n  p a t i e n t s  with cancer .  - 31 
2 1  Kaiko, Robert F . ,  e t  al. Analges ic  and Mood E f f e c t s  of Hero in  and 
~ o r ~ h h e  i n  Cancer P a t i e n t s  with P o s t o p e r a t i v e  Pain. The New England J o u r n a l  
of Medicine,  v. 304, June 18, 1981. p. 1501-5. 
3 1  I b i d . ,  ( r e sea rch  a r t i c l e  a b s t r a c t ) .  - .  
The Sloan-Ketter ing s tudy  has  been c r i t i c i z e d  because i t  was c a r r i e d  o u t  
w i t h  cance r  p a t i e n t s  who were exper ienc ing  p a i n  fo l lowing  su rge ry .  - 41 BY corn- 
p a r i s o n ,  t h e  Georgetown Un ive r s i t y  s tudy  was conducted wi th  t e r m i n a l l y  ill 
p a t i e n t s  w i t h  moderate and seve re  pain.  The medical  team a t  George town a l s o  
found morphine and he ro in  t o  be equa l ly  e f f e c t i v e ,  but they noted t h a t  h e r o i n ,  
having g r e a t e r  potency and s o l u b i l i t y ,  would be very u s e f u l  i n  t r e a t i n g  p a t i e n t s  
who have developed a  high l e v e l  of t o l e r a n c e  t o  o t h e r  drugs .  - 51  
Fran a  pharmacological s t a n d p o i n t ,  i t  appears  t h a t  he ro in  has  no a n a l g e s i c  
s u p e r i o r i t y  over  morphine o r  even some o t h e r  powerful n a r c o t i c s  such a s  hydro- 
morphone (D i l aud id )  o r  methadone (Dolophine, e t c .  ). In  a d d i t i o n ,  t h e  Food and 
Drug Adminis t ra t ion  has  r e c e n t l y  ( January  11, 1984)  approved a  new h igh  potency 
fo rmula t ion  of hydranorphone named Di laudid  UP. FDA noted i n  i t s  p r e s s  r e l e a s e  
t h a t  t h e  drug " w i l l  provide pa in  r e l i e f  a s  g r e a t  a s  can be o b t a i n e d  wi th  any 
o t h e r  n a r c o t i c ,  i nc lud ing  he ro in ,  and can be d e l i v e r e d  i n  a  very  small volume." 
The p o l i c y  ques t i on  t h a t  remains i s  whether o r  no t  h e r o i n  should be r e -  
scheduled a s  a  c o n t r o l l e d  subs t ance ,  and be made a v a i l a b l e  a long w i t h  o t h e r  
o p i a t e  a n a l g e s i c s  t o  t r e a t  i n t r a c t a b l e  pa in ,  e s p e c i a l l y  pa in  so  o f t e n  encountered 
by p a t i e n t s  w i th  te rmina l  i l l n e s s e s  such a s  cancer .  During t h e  1981 annual  
meeting of t h e  American Medical Assoc ia t ion ,  t h e  AMA House of Delega tes  adopted 
t h e  fo l lowing  r e s o l u t i o n :  
Resolved , t h a t  t h e  American Medical Assoc i a t i on  endorsed t h e  
p r i n c i p l e  t h a t  t he  management of pa in  r e l i e f  i n  t e rmina l  can- 
c e r  p a t i e n t s  should be a  medical d e c i s i o n  and should take  
p r i o r i t y  over- concerns about drug dependence. - 61  
41 Quat t lebaum, J u d i t h  U. L e t t e r  t o  t h e  E d i t o r .  The Washington P o s t ,  - 
J u l y  7, 1981. p. A30. 
51 Pe r sona l  caumunication wi th  D r .  William Beaver. Department of Oncology, 
~ e o r ~ e t o w n  U n i v e r s i t y ,  J u l y  7 ,  1981. 
61'  Reso lu t ion  introduced by D r .  Roger J. Smith, De lega t e ,  American 
p s y c h i a t r i c  Assoc i a t i on ,  and adopted by t h e  American Medical A s s o c i a t i o n ,  
June  9 ,  1981, du r ing  t h e i r  annual meeting. 
Although t h i s  r e s o l u t i o n  avoided mentioning any s p e c i f i c  d rugs  f o r  p a i n  
r e l i e f ,  h e r o i n  o r  o the rwi se ,  i t  coincided w i t h  v a r i o u s  l e g i s l a t i v e  i n i t i a t i v e s  
i n t roduced  i n  t h e  Congress r e l a t e d  t o  t he  use of he ro in  f o r  pa in .  I n  t h e  
9 6 t h  and 9 7 t h  Congresses ,  Representa t ive  Edward Madigan in t roduced  l e g i s l a t i o n  
t o  a u t h o r i z e  t h e  use of he ro in  f o r  t e rmina l ly  ill cancer  p a t i e n t s ,  and a  
hea r ing  was he ld  by t h e  House Committee on I n t e r s t a t e  and Fore ign  Commerce, 
Subcommittee on Heal th  and t h e  Environment on September 4 ,  1980. S imi l a r  l e g i s l a -  
t i o n  was introduced by Representa t ive  Henry Waxman i n  t he  97 th  Congress and 
r e f e r r e d  t o  t h e  House Committee on Energy and Commerce. Although t h e  language 
of t h e  two b i l l s  d i f f e r e d ,  t h e  i n t e n t  of each was t o  amend t h e  a p p r o p r i a t e  
s t a t u t e s  t o  permit  t h e  d i spens ing  of he ro in  f o r  pa in  r e l i e f  on ly  t o  i n d i v i d u a l s  
w i t h  t e rmina l  cancer .  Sena tor  Daniel  K. Inouye a l s o  in t roduced  a  he ro in  b i l l  
i n  t h e  97 th  Congress t h a t  would amend t h e  Cont ro l led  Subs tances  Act and d i r e c t  
t h e  S e c r e t a r y  of Hea l th  and Human Se rv i ce s  t o  e s t a b l i s h  a  temporary he ro in  
program under which c o n f i s c a t e d  he ro in  would be made a v a i l a b l e  t o  pharmacies 
of q u a l i f i e d  h o s p i t a l s  f o r  dispensing t o  cancer  p a t i e n t s  f o r  t h e  r e l i e f  of 
pain.  The b i l l  was r e f e r r e d  t o  t h e  Committee on Labor and Human Resources ,  
and r e q u e s t s  f o r  execut ive  comment e r e  sought from t h e  Department of Hea l th  
and Human Se rv i ce s  and t h e  Of f i ce  on Management and Budget. 
Thus f a r ,  i n  t h e  9 8 t h  Congress,  two b i l l s  have been in t roduced  i n  an 
e f f o r t  t o  make he ro in  a v a i l a b l e  under l i m i t e d  c i rcumstances .  On January  2 6 ,  
1983, Sena to r  Inouye re in t roduced  h i s  l e g i s l a t i o n  (S. 209) from t h e  previous 
Congress. On February 6 ,  1984, Representa t ive  Waxman in t roduced  H.R. 4762 
which would d i r e c t  t h e  Sec re t a ry  (DHHS) t o  e s t a b l i s h  a  6 h o n t h  program under 
which h e r o i n  would be made a v a i l a b l e  by p r e s c r i p t i o n  through q u a l i f i e d  
pharmacies.  Hearings on Representa t ive  Waxman's proposal  were he ld  on 
March 8: 1984, by t h e  Committee on Energy and Commerce, Subcommittee on 
CRS- 6 
Health and t h e  Environment. By narrowing the f i e l d  of po tent ia l  p a t i e n t s  tha t  
might require strong pain r e l i e f  ( i . e . ,  those terminally ill with  cancer) ,  these  
l e g i s l a t i v e  e f f o r t s  would a l low l imited  use  of heroin i n  medical p r a c t i c e ,  and 
a s  a  r e s u l t  reduce the opportunit ies  f o r  po tent ia l  i l l i c i t  d ivers ion .  
